Sarah Kathryn Rouan
Director, NAVIDEA BIOPHARMACEUTICALS, INC.
Companies
- Viking TherapeuticsBoard member Jul 2, 2019 to now1
- NAVIDEA BIOPHARMACEUTICALS, INC.Board member Dec 12, 2018 to Jul 7, 20212
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Viking Therapeutics VKTX4,390 shares3$110.2K at $25.11Jan 2, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jan 2, 2026Granted 3,150 shares of Viking Therapeutics3
- Mar 31, 2025Bought 1,240 shares at $24.15 of Viking Therapeutics4
- Mar 31, 2025Bought 1,240 shares at $24.15 of Viking Therapeutics5
- Oct 25, 2024Sold 11,000 shares at $80.89 of Viking Therapeutics6
- Oct 25, 2024Exercised options 11,000 shares at $4.88 of Viking Therapeutics6
- Feb 8, 2024Sold 25,000 shares at $28.05 of Viking Therapeutics7
- Feb 8, 2024Exercised options 25,000 shares at $8.32 of Viking Therapeutics7
- Jan 19, 2024Sold 30,000 shares at $23.05 of Viking Therapeutics8
- Jan 19, 2024Exercised options 30,000 shares at $8.32 of Viking Therapeutics8
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARViking Therapeutics, Board member
- 2
- 3
- 4SEC EDGARForm 4 filed Apr 8, 2025
- 5SEC EDGARForm 4 filed Apr 2, 2025
- 6SEC EDGARForm 4 filed Oct 25, 2024
- 7SEC EDGARForm 4 filed Feb 8, 2024
- 8SEC EDGARForm 4 filed Jan 19, 2024